Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit

Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit : New Recommendations do They Change Our Clinical Practice ?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03217721

Acronym

REANEUF

Enrollment

130

Registered

2017-07-14

Start date

2017-06-19

Completion date

2017-09-19

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neutropenia, Febrile

Brief summary

Neutropenia, defined by an absolute count of polymorphonuclear neutrophils less than \<1500/mm3, exposes patients to infectious complications that can lead to sepsis or septic shock. The mortality risk is higher risk. The recommendations published in 2016 were formulated to homogenize the clinical practices to improve the survival.

Detailed description

We evaluate the adequacy antibiotics prescriptions in febrile neutropenia with suspected infection and evaluate factors influencing adequacy therapy and mortality consequence.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Sepsis or septic shock at admission or during the stay

Exclusion criteria

* Minor * Pregnancy * Opposition

Design outcomes

Primary

Measure	Time frame	Description
Proportion of adequate antibiotic prescription	Through study completion, an average of 1 month	Proportion of adequate antibiotic prescription

Secondary

Measure	Time frame	Description
Mortality of all causes	ICU, hospital and 28-day mortality	Mortality of all causes

Countries

France

Outcome results